A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation

      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kelton J.G.
        Antiplatelet agents: rationale and results.
        Clinics in Haematology. 1983; 12: 311-354
        • Smith J.B.
        • Willis A.L.
        Aspirin selectively inhibits prostaglandin production in human platelets.
        Nat. New Biol. 1971; 231: 235-237
        • Burch J.W.
        • Stanford N.
        • Majerus P.W.
        Inhibition of platelet prostaglandin synthetase by oral aspirin.
        J. Clin. Invest. 1978; 61: 314-319
        • Biggs D.F.
        • Coutts R.T.
        • Walter L.J.
        A note on the bioavailability of five Canadian brands of acetylsalicylic acid tablets.
        Can. J. Pharm. Sci. 1977; 12: 23-25
        • Rowland M.
        • Riegelman S.
        • Harris P.A.
        • Sholkoff S.D.
        Absorption kinetics of aspirin in man following oral administration of an aqueous solution.
        J. Pharmaceut. Sci. 1972; 61: 379-385
        • Rosenfeld J.
        • Phatak A.
        • Tiny I.Z.
        • Lawrence W.
        The mass spectrometric determination of aspirin via extractive alkylation.
        Anal. Letters. 1980; 13: 1373-1387
        • Kelton J.G.
        • Carter C.J.
        • Rosenfeld J.
        • Massicotte-Nolan M.P.
        • Hirsh J.
        Sex-related differences in the efficacy of acetylsalicylic acid (ASA): the absorption of ASA and its effect on collagen-induced thromboxane B2 generation.
        Thromb. Res. 1981; 24: 163-168
        • Brantmark B.
        • Wahlin-Boll E.
        • Melander A.
        Bioavailability of acetylsalicylic acid and salicylic acid from rapid- and slow-release formulations, and in combination with dipyridamole.
        Eur. J. Clin. Pharmaco. 1982; 22: 309-314
        • Ali M.
        • McDonald J.W.
        • Thiessen J.J.
        • Coates P.E.
        Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
        Stroke. 1980; 11: 9-13